Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 19 (TTTY19) is a long non-coding RNA gene located on the Y chromosome, primarily or exclusively expressed in human testis[1][3][7]. It belongs to the class of non-protein coding RNAs, meaning it does not encode a protein but is transcribed into RNA potentially involved in gene regulatory functions[1][3][4][7]. Like other lncRNAs, it may participate in the regulation of chromatin state, transcription, or post-transcriptional gene expression, but specific molecular roles or disease associations for TTTY19 itself have not been described in current databases or literature[2][6][8]. It is not recognized as a therapeutic target, nor are there any known drugs, biomarkers, or clinical safety concerns directly linked to it[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 19 (TTTY19).